Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12957809 | 0.95 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL17083647 | 0.95 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL26498502 | 0.95 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL50372 | 0.95 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL19051889 | 0.92 | TSHR (0.43) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL8758845 | 0.92 | ALDH1A1 (0.40) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL16977288 | 0.90 | ALDH1A1 (0.41) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL22540509 | 0.90 | ALDH1A1 (0.41) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL15683202 | 0.90 | ALDH1A1 (0.41) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL28630227 | 0.90 | ALDH1A1 (0.41) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170096577-A1 | PRIMER-LESS COATED SUBSTRATES | PRC-DESOTO INTERNATIONAL, INC. | 2017-04-06 | — | — | US | disclosed |
| US-8030401-B1 | Photoinitiated cationic epoxy compositions | HENKEL CORPORATION (US) | 2011-10-04 | — | — | US | disclosed |
| US-7714037-B1 | Photoinitiated cationic epoxy compositions and articles exhibiting low color | HENKEL CORPORATION (US) | 2010-05-11 | — | — | US | disclosed |
| US-20100035003-A1 | COMPOSITIONS POLYMERIZABLE/CROSSLINKABLE BY CATIONIC/RADICAL IRRADIATION | PERSTORP FRANCE (FR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035003-A1 | COMPOSITIONS POLYMERIZABLE/CROSSLINKABLE BY CATIONIC/RADICAL IRRADIATION | XRCC6, XRCC5, ERCC1 | ALDH1A1 2810/4885TSHR 4474/4885MAPK1 3646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.